Core Laboratories Company Insiders

CLB Stock  USD 16.97  0.21  1.22%   
About 56% of Core Laboratories' corporate insiders are selling. The analysis of insiders' sentiment of trading Core Laboratories NV stock suggests that many insiders are alarmed at this time. Core Laboratories employs about 3.6 K people. The company is managed by 36 executives with a total tenure of roughly 190 years, averaging almost 5.0 years of service per executive, having 100.0 employees per reported executive.
Lawrence Bruno  Chairman
Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
David Demshur  Chairman
Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer

Core Laboratories' Insider Buying Vs Selling

44

 
Selling
 
Buying

Latest Trades

2020-05-07Jan Willem SodderlandAcquired 600 @ 17.07View
2020-02-03Lawrence BrunoAcquired 3000 @ 34.86View
2020-01-02Mark F. ElvigDisposed 600 @ 37.93View
2019-08-13Gregory Barry BarnettAcquired 1000 @ 40View
2019-03-11Kevin DanielsDisposed 428 @ 66.25View
2018-10-29Jan Willem SodderlandAcquired 200 @ 85.76View
2018-08-14Kevin DanielsDisposed 73 @ 112.63View
2017-02-01Michael StraughenAcquired 106 @ 118.65View
2017-01-30Martha Z CarnesAcquired 200 @ 115.2View
2016-02-02Jan Willem SodderlandAcquired 300 @ 93.9View
2015-05-12Michael C KearneyDisposed 1000 @ 128.52View
2014-11-17Mark F ElvigDisposed 1000 @ 138.03View
2014-07-28Richard L BergmarkAcquired 7000 @ 147.31View
2014-03-07Michael KearneyDisposed 2000 @ 193View
2014-02-14Mark ElvigDisposed 1500 @ 186.64View
2013-10-21Monty L DavisDisposed 5704 @ 197.33View
2013-08-07Richard BergmarkDisposed 20000 @ 149.58View
2013-07-25Monty L DavisDisposed 5948 @ 149.12View
Monitoring Core Laboratories' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Core Laboratories' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Core Laboratories' future performance. Based on our forecasts, it is anticipated that Core will maintain a workforce of about 3900 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Core Laboratories' latest congressional trading

Congressional trading in companies like Core Laboratories, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Core Laboratories by those in governmental positions are based on the same information available to the general public.
2018-12-10Representative Thomas J. RooneyDisposed $15K to $50KVerify
2018-04-24Senator Shelley Moore CapitoAcquired Under $15KVerify
2018-04-24Senator Shelley M CapitoAcquired Under $15KVerify

Core Laboratories Management Team Effectiveness

The company has Return on Asset of 0.0605 % which means that on every $100 spent on assets, it made $0.0605 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1768 %, implying that it generated $0.1768 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.15. The current year's Return On Capital Employed is expected to grow to 0.21. At present, Core Laboratories' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.
As of April 23, 2024, Common Stock Shares Outstanding is expected to decline to about 40.8 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 21.3 M

Core Laboratories Workforce Comparison

Core Laboratories NV is number one stock in number of employees category among related companies. The total workforce of Energy industry is currently estimated at about 16,775. Core Laboratories totals roughly 3,600 in number of employees claiming about 21% of equities under Energy industry.

Core Laboratories Profit Margins

The company has Net Profit Margin of 0.07 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.13 %, which entails that for every 100 dollars of revenue, it generated $0.13 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.20.1845
Significantly Up
Slightly volatile
Operating Profit Margin0.140.1055
Significantly Up
Slightly volatile

Core Laboratories Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Core Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-06-01
1.5714
11
7
 65,005 
 35,434 
2022-12-01
0.4286
6
14
 133,922 
 205,018 
2022-06-01
0.6
6
10
 27,675 
 33,386 
2022-03-01
1.75
7
4
 215,566 
 334.00 
2021-12-01
0.5
8
16
 79,962 
 111,193 
2021-09-01
1.8
9
5
 31,546 
 302.00 
2021-06-01
0.8571
12
14
 112,884 
 111,265 
2021-03-01
2.0
6
3
 156,152 
 175.00 
2020-12-01
0.4545
5
11
 21,622 
 30,301 
2020-09-01
0.5
1
2
 105.00 
 152.00 
2020-06-01
0.9048
19
21
 114,026 
 31,400 
2020-03-01
2.25
9
4
 288,626 
 774.00 
2019-12-01
0.4167
5
12
 66,440 
 102,746 
2019-09-01
1.5
3
2
 3,105 
 146.00 
2019-06-01
0.7692
20
26
 27,440 
 14,293 
2019-03-01
1.1429
8
7
 128,538 
 908.00 
2018-12-01
0.5833
7
12
 63,135 
 84,730 
2018-09-01
0.4545
5
11
 655.00 
 944.00 
2018-06-01
0.7778
14
18
 16,269 
 16,155 
2018-03-01
1.5
12
8
 100,592 
 8,279 
2017-12-01
0.6364
7
11
 85,705 
 116,538 
2017-09-01
0.5
1
2
 125.00 
 160.00 
2017-06-01
4.0
8
2
 9,146 
 71.00 
2017-03-01
1.0833
13
12
 79,994 
 5,103 
2016-12-01
0.5
6
12
 38,423 
 53,104 
2016-09-01
0.6667
2
3
 1,460 
 160.00 
2016-06-01
2.6667
8
3
 9,398 
 71.00 
2016-03-01
0.9286
13
14
 108,443 
 8,377 
2015-12-01
0.5
6
12
 55,935 
 74,910 
2015-09-01
1.0
2
2
 425.00 
 160.00 
2015-06-01
1.6
8
5
 9,916 
 2,656 
2015-03-01
1.25
10
8
 87,569 
 5,760 
2014-12-01
0.4
6
15
 61,104 
 108,886 
2014-06-01
1.1
11
10
 8,336 
 4,842 
2014-03-01
1.2222
11
9
 45,155 
 8,681 
2013-12-01
0.3846
5
13
 65,207 
 97,235 
2013-06-01
1.2222
11
9
 10,116 
 7,050 
2013-03-01
0.8333
10
12
 63,670 
 17,919 
2012-12-01
0.55
11
20
 67,731 
 90,174 
2012-09-01
0.625
5
8
 9,265 
 9,275 
2012-06-01
1.0714
15
14
 16,124 
 19,031 
2012-03-01
0.8333
10
12
 66,018 
 42,349 
2011-12-01
1.0
2
2
 409.00 
 506.00 
2011-09-01
0.0625
1
16
 9.00 
 271,598 
2011-06-01
1.3571
19
14
 82,900 
 33,354 
2011-03-01
0.4444
4
9
 5,000 
 16,381 
2010-12-01
0.5
1
2
 400.00 
 506.00 
2010-09-01
0.1765
6
34
 24,000 
 483,626 
2010-06-01
1.2
18
15
 39,240 
 8,332 
2010-03-01
0.2857
4
14
 2,500 
 191,229 
2009-12-01
0.125
3
24
 600.00 
 214,113 
2009-09-01
1.0
12
12
 18,942 
 14,093 
2009-06-01
0.7
7
10
 6,400 
 4,049 
2009-03-01
1.4444
13
9
 5,967 
 3,470 
2008-12-01
0.5
1
2
 200.00 
 253.00 
2008-09-01
0.3333
6
18
 4,452 
 34,220 
2008-06-01
0.6667
4
6
 4,600 
 3,363 
2008-03-01
0.0338
9
266
 137,400 
 325,183 
2007-09-01
0.0286
6
210
 12,000 
 165,605 
2007-06-01
0.1667
9
54
 8,000 
 16,993 
2007-03-01
0.0879
32
364
 1,321,392 
 2,106,651 
2006-09-01
5.0
5
1
 10,000 
 2,000 
2006-06-01
0.5714
4
7
 21,000 
 10,984 
2005-06-01
1.0
4
4
 76,199 
 76,199 
2002-06-01
1.0
2
2
 37,712 
 38,487 

Core Laboratories Notable Stakeholders

A Core Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Core Laboratories often face trade-offs trying to please all of them. Core Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Core Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lawrence BrunoChairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating OfficerProfile
David DemshurIndependent Chairman of the Board of Supervisory Directors and Chief Executive OfficerProfile
Tahera KhanVice President Human ResourcesProfile
Gwendolyn SchrefflerSenior Vice President, Corporate Development and Investor RelationsProfile
Michael FleckerVice President Production EnhancementProfile
Christopher HillChief Financial Officer, Senior Vice PresidentProfile
Alastair CrombieVice President Reservoir DescriptionProfile
Mark ElvigSenior Vice President, Secretary, and General CounselProfile
David HumeVice President Reservoir DescriptionProfile
Kevin DanielsVice President, Chief Accounting OfficerProfile
James GreshamSenior Vice President Business DevelopmentProfile
Peter BoksVice President Reservoir DescriptionProfile
Jeffrey WestVice President Production EnhancementProfile
DumasVice President Business DevelopmentProfile
Monty DavisCOO and Sr. VPProfile
Charles DunlapIndependent Member of the Board of Supervisory DirectorsProfile
Richard BergmarkCFO, Executive VP and Supervisory DirectorProfile
Michael KearneyIndependent Supervisory DirectorProfile
Margaret KempenIndependent Member of the Board of Supervisory DirectorsProfile
Lucia GeunsIndependent Member of the Board of Supervisory DirectorsProfile
Jan SodderlandIndependent Member of the Board of Supervisory DirectorsProfile
Sow TeoTreasurer VPProfile
Chris HillChief Accounting Officer and VPProfile
Monique EeuwijkNon-Executive Independent Member of the Supervisory BoardProfile
D OgrenMember of the Supervisory BoardProfile
Harvey KlingensmithNon-Executive Independent Member of the Supervisory BoardProfile
Michael StraughenNon-Executive Independent Member of the Supervisory BoardProfile
John OgrenMember of the Supervisory BoardProfile
Gwendolyn MBASenior RelationsProfile
J DumasVice President Business DevelopmentProfile
Martha CarnesPresiding Non-Executive Lead Independent Member of the Supervisory BoardProfile
Jacobus SchoutenManaging DirectorProfile
Kwaku TemengNon-Executive Independent Member of the Supervisory BoardProfile
Gregory BarnettNon-Executive Independent Member of the Supervisory BoardProfile
Mark TattoliSenior Vice President General Counsel, SecretaryProfile
Gwendolyn GreshamSenior Vice President Corporate Development and Investor RelationsProfile

About Core Laboratories Management Performance

The success or failure of an entity such as Core Laboratories often depends on how effective the management is. Core Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Core management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Core management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.15 
Return On Capital Employed 0.11  0.21 
Return On Assets 0.06  0.10 
Return On Equity 0.16  0.32 
The data published in Core Laboratories' official financial statements usually reflect Core Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Core Laboratories. For example, before you start analyzing numbers published by Core accountants, it's critical to develop an understanding of what Core Laboratories' liquidity, profitability, and earnings quality are in the context of the Energy Equipment & Services space in which it operates.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Core Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Laboratories NV. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.

Core Laboratories Workforce Analysis

Traditionally, organizations such as Core Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Core Laboratories within its industry.

Core Laboratories Manpower Efficiency

Return on Core Laboratories Manpower

Revenue Per Employee141.6K
Revenue Per Executive14.2M
Net Income Per Employee10.2K
Net Income Per Executive1M
Working Capital Per Employee30.2K
Working Capital Per Executive3M
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Dividend Share
0.04
Earnings Share
0.51
Revenue Per Share
10.92
Quarterly Revenue Growth
0.005
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.